Morning Briefing
Summaries of health policy coverage from major news organizations
Last-Resort Antibiotic Still Being Used In Livestock
A study published this week in The Lancet Microbe shows that, despite global concerns about resistance, the last-resort antibiotic colistin is still being traded and widely used for growth promotion and disease prevention in food-producing animals in some low- and middle-income countries (LMICs). (Dall, 3/17)
The business-friendly tax reform enacted in 2017, under the watch of former President Donald Trump, allowed some of the pharma industry’s top companies to slash much of their tax burden. (Dunleavy, 3/21)
The U.S. government will not force Pfizer Inc and Astellas Pharma Inc to lower the price of their prostate cancer drug Xtandi using its emergency "march-in" authority, the National Institutes of Health (NIH) said on Tuesday. (3/21)
Six months after Takeda’s dengue vaccine Qdenga scored its first approval in Indonesia, another large dengue-affected country has signed off on the shot. And with a Brazilian approval in hand, the company has unveiled its pricing and access approach to the key launch. (Becker, 3/21)
Cyclooxygenase inhibitors are commonly used in infants with patent ductus arteriosus (PDA), but the benefit of these drugs is uncertain. (Hundscheid, M.D., et al, 3/16)
